According to an article at OsseoNews.com, Nobel Biocare’s third-quarter earnings have plummeted below already low expectations. For the independently owned dental practice, investing in products and equipment has a direct link to the owner’s personal finances. Keeping a low inventory on hand is just practical in this economic atmosphere, and many dentists are playing it safe.
In Asia, Nobel Biocare’s stocks are holding strong, but that is predicted to change as the US economical slowdown spreads to affect other nations’ economies. Even with this disappointing news, Nobel Biocare is taking long strides in product development, with NobelActive extensions and innovative components scheduled to hit the market in early 2009. Nobel Biocare is also working on digital dentistry, having gone into a business deal with Imaging Sciences International (ISI).